Literature DB >> 11122717

Diet and hemostatic factors.

R P Tracy1.   

Abstract

The coagulation, fibrinolytic, and platelet activating systems are complex and interact extensively, and with other systems such as inflammation. Key reactions often require biomembranes, suggesting that dietary lipids, to the extent that they influence membrane composition, may have important regulatory roles. Also, recent evidence suggests that both postprandial and fasting lipoproteins may be associated with either factor levels or activation state or both. This issue has added importance because several hemostatic and fibrinolytic factors are known CVD risk factors. Although there are associations between fasting lipid levels and several coagulation and fibrinolytic factors, the mechanisms are unclear, as are the implications for intervention. In general, postprandial lipids are at least somewhat procoagulant because they activate factor VII. It remains to be demonstrated, however, that this postprandial activation has important clinical correlates. Dietary supplementation with marine omega-3 fatty acids does prolong the bleeding time and may decrease thrombotic potential; however, other than this, little is known about the direct effects of dietary fatty acids on hemostatic and fibrinolytic activities. Much work is needed in carefully controlled studies to expand our knowledge in this important area.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11122717     DOI: 10.1007/s11883-999-0039-1

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.967


  72 in total

Review 1.  Surface-dependent reactions of the vitamin K-dependent enzyme complexes.

Authors:  K G Mann; M E Nesheim; W R Church; P Haley; S Krishnaswamy
Journal:  Blood       Date:  1990-07-01       Impact factor: 22.113

2.  Hemostatic factors in hypertriglyceridemic men: effects of a fatty meal before and after triglyceride-lowering treatment with etofibrate.

Authors:  M Orth; H Mayer; M Halle; C Luley
Journal:  Thromb Res       Date:  1999-06-15       Impact factor: 3.944

3.  Clinical implications of the protein C/protein S system.

Authors:  P C Comp
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

4.  Evidence for inflammation as a cause of hypocholesterolemia in older people.

Authors:  W H Ettinger; T Harris; R B Verdery; R Tracy; E Kouba
Journal:  J Am Geriatr Soc       Date:  1995-03       Impact factor: 5.562

5.  Association of factor VII:C levels with environmental and genetic factors in patients with ischaemic heart disease and coronary atheroma characterised by angiography.

Authors:  D M Heywood; N Ossei-Gerning; P J Grant
Journal:  Thromb Haemost       Date:  1996-08       Impact factor: 5.249

6.  Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Folsom; K K Wu; W D Rosamond; A R Sharrett; L E Chambless
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

7.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

8.  Dietary oleic and palmitic acids and postprandial factor VII in middle-aged men heterozygous and homozygous for factor VII R353Q polymorphism.

Authors:  T A Sanders; T de Grassi; G J Miller; S E Humphries
Journal:  Am J Clin Nutr       Date:  1999-02       Impact factor: 7.045

9.  Factor VII-phospholipid complex in male survivors of acute myocardial infarction.

Authors:  K Dalaker; P Smith; H Arnesen; H Prydz
Journal:  Acta Med Scand       Date:  1987

10.  Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition.

Authors:  G J Miller; J C Martin; K A Mitropoulos; B E Reeves; R L Thompson; T W Meade; J A Cooper; J K Cruickshank
Journal:  Atherosclerosis       Date:  1991-02       Impact factor: 5.162

View more
  1 in total

1.  Decreased low-density lipoprotein and the presence of pulmonary arterial hypertension among newly diagnosed drug-naïve patients with systemic lupus erythematosus: D-dimer as a mediator.

Authors:  Jing Huang; Qi An; Cai-Lian Zhang; Lan He; Lei Wang
Journal:  Exp Ther Med       Date:  2022-07-27       Impact factor: 2.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.